# Sean J. Barbour

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sean-j-barbour/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,461 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 33 |
| i10-index | 54 |
| Last Known Institution | Provincial Health Services Authority |
| OpenAlex ID | https://openalex.org/A5111973651 |
| Works | 86 |

## Researcher papers

Showing 12 of 15.

- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Evaluating a New International Risk-Prediction Tool in IgA Nephropathy](https://scholariq.org/papers/evaluating-a-new-international-risk-prediction-tool-in-iga-nephropathy/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial](https://scholariq.org/papers/effects-of-the-sglt2-inhibitor-dapagliflozin-on-proteinuria-in-non-diabetic/)
- [Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis](https://scholariq.org/papers/disease-specific-risk-of-venous-thromboembolic-events-is-increased-in-idiopathic/)
- [Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-2-conclusions-from-a-kidney/)
- [Risk Stratification of Patients With IgA Nephropathy](https://scholariq.org/papers/risk-stratification-of-patients-with-iga-nephropathy/)
- [Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease](https://scholariq.org/papers/individuals-of-pacific-asian-origin-with-iga-nephropathy-have-an-increased-risk/)
- [Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification](https://scholariq.org/papers/mayo-clinic-consensus-report-on-membranous-nephropathy-proposal-for-a-novel/)
- [Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy](https://scholariq.org/papers/personalized-prophylactic-anticoagulation-decision-analysis-in-patients-with/)
- [IgA Nephropathy: Epidemiology and Disease Risk Across the World](https://scholariq.org/papers/iga-nephropathy-epidemiology-and-disease-risk-across-the-world/)
- [Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada](https://scholariq.org/papers/disease-specific-incident-glomerulonephritis-displays-geographic-clustering-in/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Provincial Health Services Authority](https://scholariq.org/institutions/provincial-health-services-authority/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.